SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-14-000194
Filing Date
2014-11-25
Accepted
2014-11-25 08:50:46
Documents
3
Period of Report
2014-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rgbp20141124form8k.htm 8-K 24896
2 ASSIGNMENT OF INVENTION AND PATENT APPLICATION rgbp20141124form8kex10_1.htm EX-10.1 15829
3 CONSULTING AGREEMENT rgbp20141124form8kex10_2.htm EX-10.2 23023
  Complete submission text file 0001607062-14-000194.txt   64829
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 333-191725 | Film No.: 141247853
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1